Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02972034
Brief Title: Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013)

First Submitted : November 21, 2016
First Submitted that Met QC Criteria : November 21, 2016
First Posted : November 23, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 19, 2019
Last Update Posted : July 23, 2019